FLNA logo

Filana Therapeutics, Inc.

FLNA
Healthcare|Biotechnology|US
$0.45
+0.00 (+0.38%)
DCF Value
$1.85
Tangible Book / Share
$1.20
Cash / Share
$0.97

Ownership Breakdown

97.1%
Float
48.3M
Shares Outstanding
46.9M
Float Shares

Major Holders (3)

Combined: 12.4%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Nachtrab MatthewIndividual4.70%2,267,636Nov 26, 202413D/G
The Vanguard GroupInvestment adviser4.49%2,170,072Jul 29, 202513D/G
BlackRock, Inc.Holding company3.20%1,545,375Jul 16, 202513D/G

Insider Trades (3)

Last 4 quarters: 399,904 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Barry Richarddirector, officer: President & CEOSep 30, 2026BUY100,000$0.92$92.0KForm 4
Barry Richarddirector, officer: President & CEOSep 29, 2026BUY206,813$0.90$186.1KForm 4
Barry Richarddirector, officer: President & CEOSep 28, 2026BUY93,091$0.84$78.2KForm 4